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Use of thiolated oligonucleotides as anti-fouling
diluents in electrochemical peptide-based
sensors†
Adam McQuistan,a Anita J. Zaitouna,a Elena Echeverriab and Rebecca Y. Lai*a
We incorporated short thiolated oligonucleotides as passivating diluents
in the fabrication of electrochemical peptide-based (E-PB) sensors, with
the goal of creating a negatively charged layer capable of resisting non-
specific adsorption of matrix contaminants. The E-PB HIV sensors
fabricated using these diluents were found to be more specific and
selective, while retaining attributes similar to the sensor fabricated
without these diluents. Overall, these results highlight the advantages
of using oligonucleotides as anti-fouling diluents in self-assembled
monolayer-based sensors.
In the past few decades, remarkable advances have been made in
medicine, specifically, in the understanding of pathogenesis of
various diseases at the molecular level. Complexities in the mole-
cular aspect of diseases have led to the development of new disease
diagnostic devices and sensors. A wide range of optical, electro-
chemical and piezoelectric biosensors have since been reported.1,2
Among them, electrochemical biosensors have proven to be useful
in disease diagnosis and monitoring, with desirable features that
include rapid response, high sensitivity, specificity and selectivity.2
To date, numerous electrochemical biosensors have been developed
for detection of biomedically relevant targets, including nucleic
acids, proteins, and small molecules.2,3
Among the currently available electrochemical biosensors
designed for detection of antibodies, the electrochemical peptide-
based (E-PB) sensors have shown to be capable of real-time and
reagentless detection of anti-HIV antibodies.4 For this class of
sensors, the peptide recognition probe is often modified with an
11-carbon alkanethiol linker at the n-terminus and a methylene
blue (MB) redox label at the c-terminus.4 In the absence of the
target antibody (IgG-target), the peptide probe is flexible, electron
transfer between the electrode and the MB label is efficient,
resulting in high MB current. In the presence of the large target
antibody, probe flexibility is significantly dampened; the limited
surface mobility is reflected by the reduction in the MB current
(Scheme 1).4 In this study, the recognition element is a 21-residue
peptide epitope (DRY-MB) from the HIV-1 p24 antigen (Fig. S1,
ESI†).5 The p24 capsid protein is known to be highly immunogenic,
the serum concentration of anti-p24 antibodies ranges from few
nanomolar to tens of nanomolar.6 The epitope used here is
different from the previously employed p24 epitope, but both are
known to be highly antigenic.4–6
Similar to the electrochemical DNA and aptamer-based sensors,
E-PB sensors are sensitive, inherently "reagentless", and easy to
operate. However, independent of the signal transduction mecha-
nism, sensor specificity and selectivity are often dependent on the
specific probe–target interaction, as well as the type of surface
passivation employed.4 Thus, the use of anti-fouling diluents to
prevent non-specific adsorption of random targets and matrix
contaminants has been implemented in the fabrication of a wide
range of sensors, in particular, self-assembled monolayer (SAM)-
based sensors designed for use with surface-plasmon resonance
spectroscopy. Thiolated oligo-ethyleneglycol (OEG) is one of the
most commonly used sensor passivating diluents, owing to its
ability to resist surface fouling.7 While thiolated OEG has
Scheme 1 Design and signalling mechanism of the E-PB sensor fabricated
with a DNA anti-fouling diluent (T2, T4 or T6).
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shown to be effective in preventing non-specific adsorption of
proteins on the sensor surface, there are other neutral or
charged diluent molecules that serve the same function. Uniformly
charged DNA, however, has not been explored for use as an anti-
fouling diluent. Thus, the goal of this study is to compare E-PB
sensors fabricated with and without DNA-based anti-fouling
diluents. The use of short DNA as diluents could prove to be
instrumental in improving sensor specificity and selectivity.
Furthermore, this sensor passivation strategy is versatile and
can potentially be used with all E-PB sensors.
To assess the effect of different DNA diluents, we designed and
fabricated four sensors using the same peptide probe. Three of
them were passivated with 6-mercapto-1-hexanol (C6-OH) and a
DNA diluent, whereas the last one was passivated with C6-OH
only. The three DNA diluents used in this study contain 2, 4, or 6
thymine (T) bases connected to a 6-carbon alkanethiol linker
(Fig. S2, ESI†). T was chosen since it is relatively flexible and is
not known to interact with matrix contaminants that can interfere
with the analysis.8 We systematically evaluated performance of the
sensors fabricated with one of the three diluents (T2, T4 or T6)
using alternating current (AC) voltammetry, with the goal of
understanding the effect of DNA diluents of different chain length
on sensor specificity and selectivity.
When interrogated using AC voltammetry, we observed a rela-
tively small yet well-definedMB reduction peak in the absence of the
target for all four systems, suggesting successful immobilization of
the peptide probe (Fig. S3, ESI†).4 The surface probe coverage was
determined using a previously developedmethod and the values are
shown in Table 1.9 The probe coverage was lower for the T2, T4, and
T6 sensors when compared to the T0 sensor (i.e., the sensor
passivated with C6-OH only), presumably because of the displace-
ment of peptide probes by the DNA diluent. All three sensors
fabricated using a DNA diluent had similar probe coverage, despite
differences in the DNA chain length. As can be seen, the sensors
responded well to 65 nM IgG-target; the observed % signal suppres-
sion (%SS) ranged from 22 to 40%, verifying the sensors’ ability to
recognize the target antibody. It is worth noting that all four sensors
responded rather rapidly independent of the addition of a DNA anti-
fouling diluent, most of the signal change (B80%) was seen in less
than 20 min after target addition. Incorporation of a DNA diluent
did not appear to have a negative impact on the binding kinetics.
Since the amount of DNA diluent being incorporated into
the monolayer can affect the overall sensor performance, the
surface coverage of the diluent has to be carefully analyzed and
monitored. Here we used X-ray photoelectron spectroscopy
(XPS) to analyze the amount of DNA diluent on the sensor
surface.10 Specifically, we analyzed the size of the phosphorous
2p peak with respect to the number of phosphate groups per
thiolated DNA strand (Fig. S4, ESI†).10 Our XPS results show a
strong inverse correlation between the diluent chain length and
surface coverage. For example, more T2 DNA strands were incor-
porated in the monolayer when compared to the larger diluents
(i.e., T4 and T6 diluents) (Table 1 and Table S1, ESI†). These
results are not unexpected since steric hindrance from the peptide
probe could affect immobilization of the larger DNA diluents.
Despite the difference in DNA diluent coverage, all three sensors
showed improved specificity when compared to the T0 sensor
(Fig. 1). For the T0 sensor,B35 %SS was evident when challenged
with 70 nM IgG-random, whereasB5 %SS was observed with the
rest of the sensors. Addition of the DNA diluent, however, did not
significantly affect the sensors’ response to IgG-target. Slightly
lower %SS was observed for both T2 and T6 sensors in the
presence of 70 nM IgG-target, but the T4 sensor showed similar
%SS as the T0 sensor. It is worth noting that a discrimination
factor (F) (F = %SSIgG-target/%SSIgG-random) ofB12 was determined
for the T4 sensor, a value much higher than that obtained for the
T0 sensor (Fig. S5, ESI†). For the T6 sensor, the lower DNA diluent
concentration could be the reason behind the lower F value. The
low F value seen with the T2 sensor could be, in part, due to the
quality of the T2 DNA diluent; purification of this probe was
rather challenging. Independent of the DNA chain length, all
three sensors showed at least a 7-fold reduction in nonspecific
binding of IgG-random when compared to the T0 sensor. These
findings corroborate with our hypothesis that the negatively
charged backbone of DNA helps in alleviating surface fouling.
However, while XPS can be used to determine surface coverage, it
does not provide information on how the thiolated DNA strands
are distributed on the sensor surface. Based on our previous
studies on SAM-based sensors, clustering of thiolatedmolecules is
not uncommon, especially for multi-component SAM systems like
the ones used in this study.11 In this case, if the anti-fouling
diluent molecules are not uniformly distributed on the sensor
surface, their ability to resist non-specific adsorption of random
targets could be hindered. We are currently working on ways to
prevent cluster formation on sensor surfaces; if successful,
specificity of these sensors could be further improved.
In addition to having fast binding kinetics, all four sensors
responded well to IgG-target, even at very low target concentra-
tions. Shown in Fig. 2A are the dose response curves for the
sensors. Although the dissociation constant (Kd) was found to
be different for each sensor, incorporation of the DNA diluent
Table 1 Peptide probe and DNA diluent coverage
Peptide probe coverage
(1010 molecules per cm2)
DNA diluent coverage
(1013 molecules per cm2)
T0 sensor 15.6  7.7 0.0
T2 sensor 3.2  0.5 9.5  1.1
T4 sensor 4.6  0.6 6.3  1.1
T6 sensor 4.7  1.2 2.7  1.4
Fig. 1 %SS recorded in the presence of 70 nM IgG-random and 70 nM
IgG-target in Phys2 for all four sensors.
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did not have a major effect on sensor sensitivity. A limit of
detection of 1 nM was determined for all four sensors. The
dynamic range was similar among the sensors, but the signal
attenuation was lower for both T2 and T4 sensors. This effect
was not observed with the T6 sensor, which behaved entirely
like the T0 sensor. This could be a result of the steric hindrance
attributed by the incorporated DNA, in which the T2 and T6
sensors had the highest and lowest DNA diluent coverage,
respectively. Further investigation is needed to elucidate the
effect of DNA diluents on signal attenuation, these aspects are
currently under investigation in the lab.
Good selectivity is another feature of the folding- and dynamics-
based electrochemical sensing platform; the previously developed
E-PB sensor for detection of HIV antibodies was characterized in
50% urine proxy.4 In this study, to determine sensor selectivity, we
interrogated all four sensors in 10% synthetic human saliva. The
noninvasive nature of salivary testing has made it an attractive
alternative to blood and urine testing in disease diagnosis.12 The
T0 sensor showed a reduction in MB current (14  1 %SS) when
used with the saliva, whereas substantially lower signal change
was observed with sensors fabricated with DNA diluents (Fig. 3).
Addition of 70 nM IgG-target resulted in 34(2), 16(3), 29(2),
and 30(2) %SS for the T0, T2, T4, and T6 sensors, respectively.
These results clearly show the advantages of using DNA diluents in
the fabrication of E-PB sensors. Other than the T2 sensor, the signal
attenuation in the presence of IgG-target was relatively similar for
all three sensors. For both T4 and T6 sensors, target recognition
was not affected by the presence of matrix contaminants. These
results further highlight the ability of these diluents in enhancing
sensor selectivity.
Here we have demonstrated the advantages of incorporating
short thiolated DNA as anti-fouling diluents in the fabrication of
E-PB sensors. Among the sensors fabricated with a DNA diluent,
the T4 sensor shows promise for real world applications. It has the
best combination of properties, which includes good signal
attenuation, specificity and selectivity. With proper optimization,
DNA diluents can potentially be used to prevent surface fouling in
sensor devices. This approach is also highly versatile; these
diluents can be used with most SAM-based biosensing platforms,
independent of the signal transduction mechanism.
The authors acknowledge theUNLUCARE program andNational
Science Foundation (GAANN #P200A100041, CHE-0955439, MRSEC
DMR-0820521) for financial support. The authors would like to
thank Dr P. A. Dowben for his help with the XPS data analysis.
Notes and references
1 (a) X. Fan, I. A. White, S. Oi. Shopova, H. Zhu, J. D. Suter and Y. Sun,
Anal. Chim. Acta, 2008, 610, 8; (b) J. Ngeh-Ngwainbi, A. A. Suleiman
and G. G. Guilbault, Biosens. Bioselectron., 1990, 5, 13; (c) D.-L. Ma,
H.-Z. He, K.-H. Leung, H.-J. Zhong, D. S.-H. Chan and C.-H. Leung,
Chem. Soc. Rev., 2013, 42, 3427; (d) H.-Z. He, D. S.-H. Chan,
C.-H. Leung and D.-L. Ma, Nucleic Acids Res., 2013, 41, 4345.
2 (a) N. J. Ronkainen, H. B. Halsall and W. R. Heineman, Chem. Soc.
Rev., 2010, 39, 1747; (b) M. Vestergaard, K. Kerman and E. Tamiya,
Sensors, 2007, 7, 3442; (c) T. G. Drummond, M. G. Hill and
J. K. Barton, Nat. Biotechnol., 2003, 21, 1192.
3 (a) K. Kerman and H.-B. Kraatz, Analyst, 2009, 134, 2400; (b) S. Zhao,
W. Yang and R. Y. Lai, Biosens. Bioelectron., 2011, 26, 2442;
(c) B. R. Baker, R. Y. Lai, M. S. Wood, E. H. Doctor, A. J. Heeger
and K. W. Plaxco, J. Am. Chem. Soc., 2006, 128, 3138.
4 (a) J. Y. Gerasimov and R. Y. Lai, Chem. Commun., 2010, 46, 395;
(b) J. Y. Gerasimov and R. Y. Lai, Chem. Commun., 2011, 47, 8688.
5 G. Tonarelli, J. Lottersberger, J. L. Salvetti, S. Jacchieri, R. A. Silva-
Lucca and L. M. Beltramin, Lett. Pept. Sci., 2000, 7, 217.
6 M. S. Cohen, C. L. Gay, M. P. Busch and F. M. Hecht, J. Infect. Dis.,
2010, 202, S270.
7 (a) K. Uchida, H. Otsuka, M. Kaneko, K. Kataoka and Y. Nagasaki,
Anal. Chem., 2005, 77, 1075; (b) E. Hifumi, N. Kubota, Y. Niimi,
K. Shimizu, N. Egashira and Y. Uda, Anal. Sci., 2002, 18, 863;
(c) H. B. Lu, C. T. Campbell and D. G. Castner, Langmuir, 2000,
16, 1711.
8 (a) Y. Wu and R. Y. Lai, Chem. Commun., 2013, 49, 3422; (b) Z. Yu and
R. Y. Lai, Chem. Commun., 2012, 48, 10523.
9 J. J. Sumner, K. S. Weber, L. A. Hockett and S. E. Creager, J. Phys.
Chem. B, 2000, 104, 7449.
10 (a) C.-Y. Lee, P. Gong, G. M. Harbers, D. W. Grainger, D. G. Castner
and L. J. Gamble, Anal. Chem., 2006, 78, 3326; (b) Z.-L. Zhang,
D.-W. Pang and R.-Y. Zhang, Bioconjugate Chem., 2002, 13, 104.
11 S. J. P. Can˜ete, Z. Zhang, L. Kong, V. L. Schlegel, B. A. Plantz,
P. A. Dowben and R. Y. Lai, Chem. Commun., 2011, 47, 11918.
12 W. Schramm, B. A. Gustavo, P. C. Torres and A. Burgess-Cassler,
Clin. Vaccine Immunol., 1999, 6, 577.
Fig. 2 Dose response curves of the four sensors obtained in Phys2 (A).
The Kd was 7, 12, 8, and 10 nM for the T0, T2, T4, and T6 sensors,
respectively. Also shown are AC voltammograms recorded for the T4
sensor in the presence of 1, 5, 10, 25, 40, 65, 80, and 100 nM IgG-target (B).
Fig. 3 %SS observed in the presence of 10% saliva and after the addition
of 70 nM IgG-target for all four sensors.
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